Achille Bregantin
Papers
1
Total Citations
233
H-Index
1
About
Achille Bregantin is a leading figure in the field of radiation oncology, with a specialized focus on stereotactic body radiotherapy (SBRT) for the treatment of prostate cancer. His most impactful contribution is a seminal 2011 study on robotic image-guided stereotactic radiotherapy for isolated recurrent primary, lymph node, or metastatic prostate cancer, which has garnered over 230 citations. This work established a critical framework for using high-precision, non-invasive radiation to target oligometastatic disease, significantly influencing modern clinical protocols for managing recurrent prostate cancer. Bregantin’s research has been instrumental in demonstrating the feasibility and efficacy of SBRT in challenging clinical scenarios, helping to shift treatment paradigms toward more targeted, less toxic interventions. His contributions are widely recognized within the radiation oncology community, and his work continues to guide both clinical practice and further research into the role of stereotactic radiotherapy in improving outcomes for patients with advanced prostate cancer.
Research Focus
Key Achievements
Top Papers
- 1